Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Here's Why You Should Add MetLife (MET) to Your Portfolio

By Zacks Investment ResearchStock MarketsJul 09, 2021 02:15AM ET
www.investing.com/analysis/heres-why-you-should-add-metlife-met-to-your-portfolio-200590713
Here's Why You Should Add MetLife (MET) to Your Portfolio
By Zacks Investment Research   |  Jul 09, 2021 02:15AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

MetLife (NYSE:MET), Inc. MET looks to have brighter days ahead with improving economy and the receding pandemic.

The company’s 2021 and 2022 earnings estimates have been revised 3.2% and 0.6% upward over the past 60 days.

The stock has a Zacks Rank #2 (Buy) at present and a Value Score of A. It has been proved time and again that a Zacks Rank #1 (Strong Buy) or 2 along with a strong Value Score of A or B provides best investment returns. You can see the complete list of today’s Zacks #1 Rank stocks here.

What’s in Store for MetLlife?

After suffering revenue decline and high claims, things are now looking up for this multiline insurer.

Revenues in the first quarter of 2021 were up 8% after declining 1% in 2020. The case for revenue growth looks strong for the insurer as the improving employment scenario is expected to drive the sales for its group benefits insurance business. A glimpse of the same was seen in the March quarter with Group Benefit insurance sales surging 45% year over year. Management also commented that the company is on track to deliver a record sales period in 2021.

Its underwriting margins will also see some respite from the COVID-led surge in claims. With the vaccination rollout, claims are expected to decline which will aid margins.

The company is also managing its investment income well. For insurers, low interest rate is a pain as they investmthe premium received and generate investment income from it. But MetLife is navigating this weak interest environment by its sound investment strategy in private equity. It is invested in domestic leveraged buyout funds, European LBOs and venture capital.

Its long-term strategy of streamlining its business by axing non-core and low return business, and focusing on the high-performing ones should pay well. In recent years, MetLife divested BrightHouse Financial, UK Wealth Management business, Hong Kong business, and MetLife Auto & Home to Farmers Insurance.

MetLife’s diversification strategy by acquiring business is also appreciative. Of late, it acquired Versant Health, a leader in vision care, PetFirst, a pet insurance company and Willing, a digital estate planning company.

Strong Capital Position and Dividend: Other Attractions

MetLife’s strategic moves are backed by its solid capital position and a strong cash generating capability. It expects to generate approximately $20 billion of free cash flow over the five-year period from 2020 through 2024, an amount equal to more than 40% of its current market capitalization.

Another attraction for its investor is its dividend payment. Recently, the company hiked its dividend by 4.3%. Over the last decade, the company’s dividend witnessed a 10% CAGR.

Stock Price Performance

Year to date, the stock has rallied 27.2% compared with the industry’s growth of 8.5%. Other stocks in the same space including Prudential Financial Inc (NYSE:PRU). PRU, American International Group Inc (NYSE:AIG). AIG and The Hartford Financial Services Group (NYSE:HIG), Inc. HIG have also jumped 31.3%, 23.5% and 27%, respectively, in the same time frame.

Zacks Investment Research
Zacks Investment Research
Image Source: Zacks Investment Research

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Hartford Financial Services Group, Inc. (HIG): Free Stock Analysis Report

American International Group, Inc. (AIG): Free Stock Analysis Report

MetLife, Inc. (MET): Free Stock Analysis Report

Prudential Financial, Inc. (PRU): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Here's Why You Should Add MetLife (MET) to Your Portfolio
 

Related Articles

Here's Why You Should Add MetLife (MET) to Your Portfolio

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email